Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2002
A rose is no longer a rose
I Craig Henderson
Oncology (Williston Park, N.Y.)
|
January 18, 2015
Bisphosphonates: game changers?
I Craig Henderson
Seminars in Oncology
|
February 22, 2005
Aromatase inhibitors in the management of early breast cancer: optimizing the clinical benefit
I Craig Henderson
Oncology (Williston Park, N.Y.)
|
May 19, 2017
With Decades of Perspective, Craig Henderson Observes That Treatment of Breast Cancer Has Come a Long Way
I Craig Henderson
Oncology (Williston Park, N.Y.)
|
April 5, 2011
Can we abandon anthracyclines for early breast cancer patients?
I Craig Henderson
Breast Cancer Research and Treatment
|
June 16, 2010
Adjuvant chemotherapy is not for everyone
I Craig Henderson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2005
Axillary surgery: clinical judgment required
I Craig Henderson
Oncology (Williston Park, N.Y.)
|
January 22, 2013
Targeted therapy: a sea change in the treatment of cancer
I Craig Henderson
Expert Review of Anticancer Therapy
|
July 14, 2007
Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy
I Craig Henderson, Vinona Bhatia
Breast Cancer Research and Treatment
|
October 11, 2003
Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole
Robert W Carlson, I Craig Henderson
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2002
A rose is no longer a rose
I Craig Henderson
Oncology (Williston Park, N.Y.)
|
January 18, 2015
Bisphosphonates: game changers?
I Craig Henderson
Seminars in Oncology
|
February 22, 2005
Aromatase inhibitors in the management of early breast cancer: optimizing the clinical benefit
I Craig Henderson
Oncology (Williston Park, N.Y.)
|
May 19, 2017
With Decades of Perspective, Craig Henderson Observes That Treatment of Breast Cancer Has Come a Long Way
I Craig Henderson
Oncology (Williston Park, N.Y.)
|
April 5, 2011
Can we abandon anthracyclines for early breast cancer patients?
I Craig Henderson
Breast Cancer Research and Treatment
|
June 16, 2010
Adjuvant chemotherapy is not for everyone
I Craig Henderson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2005
Axillary surgery: clinical judgment required
I Craig Henderson
Oncology (Williston Park, N.Y.)
|
January 22, 2013
Targeted therapy: a sea change in the treatment of cancer
I Craig Henderson
Expert Review of Anticancer Therapy
|
July 14, 2007
Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy
I Craig Henderson, Vinona Bhatia
Breast Cancer Research and Treatment
|
October 11, 2003
Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole
Robert W Carlson, I Craig Henderson
Page
of 4